145 related articles for article (PubMed ID: 23288484)
21. Clinical utility of targeted treatments in the management of epithelial ovarian cancer.
Twu C; Han ES
Biologics; 2012; 6():233-44. PubMed ID: 22904615
[TBL] [Abstract][Full Text] [Related]
22. Effect of angiogenesis inhibitors on wound healing in patients with ovarian cancer: A meta-analysis.
Li X; Zeng D; Shi J
Int Wound J; 2024 Mar; 21(3):e14737. PubMed ID: 38468423
[TBL] [Abstract][Full Text] [Related]
23. Application of anti-angiogenic drugs in ovarian cancer from the perspective of bibliometrics.
Song S; Meng S; Yin R
Asian J Surg; 2024 May; 47(5):2228-2229. PubMed ID: 38331619
[No Abstract] [Full Text] [Related]
24. Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation.
Yang Y; Wang Q; Zhan F
J Cancer; 2024; 15(4):955-965. PubMed ID: 38230220
[No Abstract] [Full Text] [Related]
25. Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.
Knapp P; Bodnar L; Błachnio-Zabielska A; Reszeć J; Świderska M; Chabowski A
Arch Med Sci; 2021; 17(1):53-61. PubMed ID: 33488856
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report.
Zhang M; Tian Z; Sun Y
Medicine (Baltimore); 2017 Nov; 96(45):e8570. PubMed ID: 29137078
[TBL] [Abstract][Full Text] [Related]
27. Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in mice.
Zhang K; Han ES; Dellinger TH; Lu J; Nam S; Anderson RA; Yim JH; Wen W
Mol Carcinog; 2017 Feb; 56(2):436-446. PubMed ID: 27253180
[TBL] [Abstract][Full Text] [Related]
28. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis-related pathways in the pathogenesis of ovarian cancer.
Gavalas NG; Liontos M; Trachana SP; Bagratuni T; Arapinis C; Liacos C; Dimopoulos MA; Bamias A
Int J Mol Sci; 2013 Jul; 14(8):15885-909. PubMed ID: 23903048
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.
Teoh D; Secord AA
Int J Gynecol Cancer; 2012 Mar; 22(3):348-59. PubMed ID: 22266932
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis inhibitors in the treatment of epithelial ovarian cancer.
Han ES; Wakabayashi M; Leong L
Curr Treat Options Oncol; 2013 Mar; 14(1):22-33. PubMed ID: 23288484
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.
Verschraegen CF; Czok S; Muller CY; Boyd L; Lee SJ; Rutledge T; Blank S; Pothuri B; Eberhardt S; Muggia F
Ann Oncol; 2012 Dec; 23(12):3104-3110. PubMed ID: 22851407
[TBL] [Abstract][Full Text] [Related]
33. Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease.
Monk BJ; Pujade-Lauraine E; Burger RA
Ann Oncol; 2013 Dec; 24 Suppl 10():x53-x58. PubMed ID: 24265406
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
Al Wadi K; Ghatage P
Expert Opin Pharmacother; 2016; 17(6):853-60. PubMed ID: 26933765
[TBL] [Abstract][Full Text] [Related]
35. Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancer.
Burger RA
Ann Oncol; 2011 Dec; 22 Suppl 8():viii65-viii68. PubMed ID: 22180405
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
